SS
OBIO icon

SBI Securities’s Orchestra BioMed OBIO Stock Holding History

SBI Securities’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26 Hold
6
– – ﹤0.01% 3796
2026
Q1 		$26 Hold
6
– – ﹤0.01% 3712
2025
Q4 		$25 Hold
6
– – ﹤0.01% 3734
2025
Q3 		$15 Sell
6
-675
-99% -$1.86K ﹤0.01% 3965
2025
Q2 		$1.82K Buy
681
+680
+68,000% +$1.99K ﹤0.01% 2422
2025
Q1 		$4 Hold
1
– – ﹤0.01% 4050
2024
Q4 		$4 Buy
+1
New +$5 ﹤0.01% 4013

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

SBI Securities's OBIO Position: Q2 2026 in Review

SBI Securities held its Orchestra BioMed (OBIO) position steady in Q2 2026 at 6 shares worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #3796.

SBI Securities first reported a position in OBIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.82K in Q2 2025. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • SBI Securities held 6 shares of Orchestra BioMed worth $26 as of Q2 2026.
  • SBI Securities left its Orchestra BioMed share count unchanged in Q2 2026.
  • Orchestra BioMed made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3796 holding.
  • SBI Securities first reported a position in Orchestra BioMed in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Orchestra BioMed position peaked at $1.82K in Q2 2025.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.